United Clinical Research Center Inc is categorized under Medical Labs in Anaheim, CA and active since 2009.
United Clinical Research Center Inc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Samir Azzam at the company’s single location by writing to 3111 West Orange Avenue # 102, Anaheim, California CA 92804 or by phoning (219) 324-2993. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | United Clinical Research Center Inc |
| Contact Person: | Samir Azzam |
| Address: | 3111 West Orange Avenue # 102, Anaheim, California 92804 |
| Phone Number: | (219) 324-2993 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
United Clinical Research Center Inc was started in 2009 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Samir Azzam for inquiries that concern United Clinical Research Center Inc by calling the company number (219) 324-2993, as your correspondence is most welcome. Additionally, the physical location of the single location of United Clinical Research Center Inc can be found at the coordinates 33.824819,-117.999397 as well as the street address 3111 West Orange Avenue # 102 in Anaheim, California 92804.
For its online presence, you may visit United Clinical Research Center Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.